CASI Pharmaceuticals advances in kidney transplant treatment and explores strategic sale in China

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a notable player in the biopharmaceutical sector, has made a significant announcement that could have wide-reaching implications for kidney transplant ... Read More